Form 6-K NYMOX PHARMACEUTICAL For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Nymox Pharma (NYMX) Reports Q1 EPS of $0.04
May 18, 2015 6:49 AM EDTNymox Pharma (NASDAQ: NYMX) reported Q1 EPS of $0.04, versus ($0.07) reported last year. Revenue for the quarter came in at $75.4 thousand, versus $78.2 thousand reported last year.
The net income in 2015 is attributable to the recognition of $2,508,533 as revenue relating to the upfront payment received from Recordati in December 2010 compared with... More
